Pembrolizumab is a prescription medicine used to treat certain types of cancer. It is a type of immunotherapy known as a monoclonal antibody that works by helping the body's own immune system fight cancer. It is used to treat advanced or metastatic melanoma, non-small cell lung cancer, head and neck cancer, classical Hodgkin lymphoma, urothelial carcinoma, and microsatellite instability-high (MSI-H) cancers. It is given as an intravenous (IV) infusion into a vein.
Pembrolizumab, sold under the brand name Keytruda, is a medication used to treat various types of cancer. It falls under a class of drugs called programmed cell death protein 1 (PD-1) inhibitors, which are a form of immunotherapy. Here's a breakdown of how it works and other important aspects of pembrolizumab:
How it Works:
Cancer cells often use a protein called PD-1 to evade the immune system's attack. Pembrolizumab acts as a PD-1 inhibitor. It binds to the PD-1 receptor on immune cells, preventing the PD-1 protein from interacting with its ligand and essentially blocking this "off switch" for the immune system. This allows the immune system to recognize and target cancer cells more effectively.
What Can Pembrolizumab Treat?
Pembrolizumab is approved for the treatment of various cancers, including:
- Melanoma (a type of skin cancer)
- Non-small cell lung cancer (NSCLC)
- Head and neck squamous cell carcinoma (HNSCC)
- Hodgkin lymphoma (a cancer of the lymphatic system)
- Urothelial carcinoma (cancer affecting the urinary tract)
- Microsatellite instability-high (MSI-H) solid tumors (cancers with specific genetic features)
- Certain other cancers, depending on the specific case and genetic factors
Dosage and Administration:
Pembrolizumab is administered as an intravenous (IV) infusion into a vein over a period of 30 to 60 minutes. The dosage and treatment schedule depend on the type of cancer being treated, the stage of the disease, and other factors determined by your doctor.
Important Considerations:
- Effectiveness: Pembrolizumab can be an effective treatment for some cancers, but it doesn't work for everyone. Your doctor will assess if you're a potential candidate for pembrolizumab therapy.
- Side Effects: Pembrolizumab can cause side effects, some common and others more serious. Common side effects include fatigue, nausea, constipation, diarrhea, cough, decreased appetite, and skin rash. Serious side effects may include immune system dysfunction, causing inflammation in various organs, infections, and neurological problems.
- Monitoring: During pembrolizumab treatment, regular monitoring with blood tests and imaging scans is crucial to assess treatment response and identify potential side effects.
Additional Notes:
- Pembrolizumab is a prescription medication and should only be taken under a doctor's supervision.
- It's vital to discuss the risks and benefits of pembrolizumab with your doctor to determine if it's the right treatment for your specific type of cancer and to understand the potential side effects.
- Immunotherapy is a developing field, and pembrolizumab is one of several PD-1 inhibitors used in cancer treatment.